Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)
China · Delayed Price · Currency is CNY 24.39
+0.99 (4.23%)
Jul 17, 2025, 2:45 PM CST
SHE:002365 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 28.72 | 61.77 | -12.31 | 140.35 | 111.42 | 105.56 | Upgrade |
Depreciation & Amortization | 112.68 | 112.68 | 135.18 | 123.62 | 115.96 | 113.07 | Upgrade |
Other Amortization | 0.16 | 0.16 | - | - | - | - | Upgrade |
Loss (Gain) From Sale of Assets | 0.33 | 0.33 | -45.02 | 0.03 | -0.25 | 0.01 | Upgrade |
Asset Writedown & Restructuring Costs | 15.88 | 15.88 | 50.3 | 4.01 | 3.02 | 15.42 | Upgrade |
Loss (Gain) From Sale of Investments | -44.11 | -44.11 | 9.04 | 18.06 | -23.76 | -23.31 | Upgrade |
Provision & Write-off of Bad Debts | -0.69 | -0.69 | -1.61 | -2.47 | 9.74 | 1.54 | Upgrade |
Other Operating Activities | 33.75 | -28.9 | -6.37 | 3.62 | 15.27 | 18.07 | Upgrade |
Change in Accounts Receivable | 36.68 | 36.68 | 18.85 | 163.25 | -172.13 | -66.87 | Upgrade |
Change in Inventory | -25.28 | -25.28 | 87.73 | -10 | -63.66 | 19.34 | Upgrade |
Change in Accounts Payable | -28.19 | -28.19 | -13.08 | -56.54 | 87.17 | 26.51 | Upgrade |
Change in Other Net Operating Assets | - | - | - | 0.94 | 22.52 | 2.68 | Upgrade |
Operating Cash Flow | 135.32 | 105.71 | 221.2 | 387.28 | 101.81 | 206.66 | Upgrade |
Operating Cash Flow Growth | -19.40% | -52.21% | -42.88% | 280.39% | -50.74% | -13.73% | Upgrade |
Capital Expenditures | -104.72 | -118.04 | -120.74 | -149.07 | -63.05 | -104.41 | Upgrade |
Sale of Property, Plant & Equipment | 1.68 | 1.89 | 0.83 | 0.38 | 0.5 | 0.67 | Upgrade |
Cash Acquisitions | - | - | - | - | -35.94 | - | Upgrade |
Divestitures | - | - | 0.13 | - | - | - | Upgrade |
Investment in Securities | -31.34 | 33.46 | -91.47 | -108.68 | 101.97 | -246.65 | Upgrade |
Other Investing Activities | 34.63 | 35.31 | 68.27 | 26.98 | 18.34 | 19.31 | Upgrade |
Investing Cash Flow | -99.75 | -47.38 | -142.99 | -230.4 | 21.83 | -331.08 | Upgrade |
Short-Term Debt Issued | - | 40.6 | 10 | 60 | 30.8 | 140.35 | Upgrade |
Total Debt Issued | 40 | 40.6 | 10 | 60 | 30.8 | 140.35 | Upgrade |
Short-Term Debt Repaid | - | -10.5 | -40 | -40 | -145.13 | -21 | Upgrade |
Total Debt Repaid | -20.5 | -10.5 | -40 | -40 | -145.13 | -21 | Upgrade |
Net Debt Issued (Repaid) | 19.5 | 30.1 | -30 | 20 | -114.33 | 119.35 | Upgrade |
Issuance of Common Stock | - | - | - | - | 3.04 | - | Upgrade |
Repurchase of Common Stock | -24.18 | -24.18 | - | - | - | - | Upgrade |
Common Dividends Paid | -23.96 | -29.82 | -35.77 | -1.57 | -30.74 | -45.47 | Upgrade |
Other Financing Activities | -29.79 | -13.5 | - | -0.62 | 2.79 | 48.56 | Upgrade |
Financing Cash Flow | -58.43 | -37.4 | -65.77 | 17.81 | -139.25 | 122.43 | Upgrade |
Foreign Exchange Rate Adjustments | 4.57 | 5.25 | 7.08 | 6.51 | -1.08 | -5.15 | Upgrade |
Net Cash Flow | -18.29 | 26.18 | 19.51 | 181.21 | -16.69 | -7.14 | Upgrade |
Free Cash Flow | 30.6 | -12.33 | 100.46 | 238.21 | 38.76 | 102.25 | Upgrade |
Free Cash Flow Growth | -37.30% | - | -57.83% | 514.53% | -62.09% | -2.76% | Upgrade |
Free Cash Flow Margin | 3.76% | -1.47% | 10.32% | 16.29% | 2.48% | 8.72% | Upgrade |
Free Cash Flow Per Share | 0.10 | -0.04 | 0.34 | 0.81 | 0.14 | 0.35 | Upgrade |
Cash Interest Paid | - | - | - | - | 0.02 | - | Upgrade |
Cash Income Tax Paid | 10.5 | 10.13 | -1.97 | 3.19 | 2.48 | 23.53 | Upgrade |
Levered Free Cash Flow | 19.09 | -39.79 | 137.21 | 208.63 | -12.28 | 47.9 | Upgrade |
Unlevered Free Cash Flow | 19.53 | -39.42 | 137.45 | 209.05 | -10.76 | 48.66 | Upgrade |
Change in Net Working Capital | -6.81 | 59.19 | -107.93 | -127.36 | 154.02 | 41.26 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.